989.2500 1.35 (0.14%)
NSE Oct 08, 2025 12:36 PM
Volume: 335.4K
 

Axis Direct
Cadila's (CDH) Q4 revenue at Rs 25.2 bn (up 6% YoY) and EBITDA at Rs 4.6 bn (down 16% YoY) were in line with estimates. PAT at Rs 3.85 bn was aided by higher other income and lower tax expense.
Zydus Lifesciences Ltd. is trading below its 30 day SMA of 1013.4
More from Zydus Lifesciences Ltd.
Recommended